Literature DB >> 17093912

Pain flare in patients with bone metastases after palliative radiotherapy--a nested randomized control trial.

D Andrew Loblaw1, Jackson Sy Wu, Peter Kirkbride, Tony Panzarella, Katherine Smith, Julie Aslanidis, Padraig Warde.   

Abstract

BACKGROUND: Short-course radiotherapy is a common treatment for the palliation of painful osseous metastases. Pain flare can be problematic, but its incidence has previously not been well-documented. The objectives of this study were to determine (1) the incidence of pain flare after palliative radiation for painful osseous metastases, and (2) whether single-fraction radiotherapy increases the risk of pain flare.
MATERIALS AND METHODS: Patients accrued to a prospective randomized control trial comparing 8 Gy in one fraction to 20 Gy in five fractions (the Canadian Bone Metastasis Study) were approached to fill out a daily pain and analgesia diary for the 7 days post-radiotherapy. Patients assessed their average pain at the index site using the Present Pain Intensity (PPI) scale of the McGill-Melzack pain questionnaire and recorded their daily analgesic medications, which were translated into an analgesic score. Pain flare was defined as a two-point increase in the PPI with no decrease in analgesic score or a 50% increase in analgesic score with no decrease in PPI on at least two consecutive days.
RESULTS: Forty-seven patients agreed to fill out the diary and 44 (94%) completed it. Fifteen of 44 (34.1%) patients experienced a pain flare that lasted a median of 3 days. Ten of 23 (43.5%) and 5/21 (23.8%) of patients who received 8 Gy and 20 Gy had a pain flare, respectively.
CONCLUSIONS: Pain flare is common after palliative radiotherapy for osseous metastases and patients receiving single fraction radiotherapy may be at higher risk. Further study is warranted to determine predictors and preventive interventions.

Entities:  

Mesh:

Year:  2006        PMID: 17093912     DOI: 10.1007/s00520-006-0166-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.359


  18 in total

1.  Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

Authors:  I F Tannock; D Osoba; M R Stockler; D S Ernst; A J Neville; M J Moore; G R Armitage; J J Wilson; P M Venner; C M Coppin; K C Murphy
Journal:  J Clin Oncol       Date:  1996-06       Impact factor: 44.544

2.  A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy.

Authors:  L Franzén; J Nyman; H Hagberg; M Jakobsson; B Sorbe; A L Nyth; H Lomberg; R Henriksson
Journal:  Ann Oncol       Date:  1996-08       Impact factor: 32.976

3.  8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party.

Authors: 
Journal:  Radiother Oncol       Date:  1999-08       Impact factor: 6.280

4.  [Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study].

Authors:  S Koswig; V Budach
Journal:  Strahlenther Onkol       Date:  1999-10       Impact factor: 3.621

5.  Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital Satisfaction With Doctor Questionnaire.

Authors:  D A Loblaw; A Bezjak; T Bunston
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

6.  Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases.

Authors:  Edward Chow; Alison Ling; Lori Davis; Tony Panzarella; Cyril Danjoux
Journal:  Radiother Oncol       Date:  2005-03-16       Impact factor: 6.280

7.  International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases.

Authors:  Edward Chow; Jackson S Y Wu; Peter Hoskin; Lawrence R Coia; Soren M Bentzen; Peter H Blitzer
Journal:  Radiother Oncol       Date:  2002-09       Impact factor: 6.280

Review 8.  Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.

Authors:  Jackson Sai-Yiu Wu; Rebecca Wong; Mary Johnston; Andrea Bezjak; Timothy Whelan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

9.  Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases.

Authors:  O S Nielsen; S M Bentzen; E Sandberg; C C Gadeberg; A R Timothy
Journal:  Radiother Oncol       Date:  1998-06       Impact factor: 6.280

10.  Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases.

Authors:  P Price; P J Hoskin; D Easton; D Austin; S G Palmer; J R Yarnold
Journal:  Radiother Oncol       Date:  1986-08       Impact factor: 6.280

View more
  18 in total

Review 1.  Treatment of painful bone metastases.

Authors:  Dirk Rades; Steven E Schild; Janet L Abrahm
Journal:  Nat Rev Clin Oncol       Date:  2010-03-16       Impact factor: 66.675

Review 2.  Management of pain in the elderly at the end of life.

Authors:  Eric Prommer; Brandy Ficek
Journal:  Drugs Aging       Date:  2012-04-01       Impact factor: 3.923

3.  Dose-Fractionation Schedules for Radiotherapy of Bone Metastases.

Authors:  Dirk Rades
Journal:  Breast Care (Basel)       Date:  2010-10-15       Impact factor: 2.860

4.  Considerations for Quality Improvement in Radiation Oncology Therapy for Patients with Uncomplicated Painful Bone Metastases.

Authors:  Anne M Walling; Phillip J Beron; Tania Kaprealian; Patrick A Kupelian; Neil S Wenger; Susan A McCloskey; Christopher R King; Michael Steinberg
Journal:  J Palliat Med       Date:  2017-02-23       Impact factor: 2.947

5.  Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational study.

Authors:  Vito Lorusso; Ignacio Duran; Cristina Garzon-Rodriguez; Diana Lüftner; Amit Bahl; John Ashcroft; Guy Hechmati; Rachel Wei; Emma Thomas; Herbert Hoefeler
Journal:  Mol Clin Oncol       Date:  2014-06-27

6.  Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases.

Authors:  Dawn Owen; Nadia N Laack; Charles S Mayo; Yolanda I Garces; Sean S Park; Heather J Bauer; Kathryn Nelson; Robert W Miller; Paul D Brown; Kenneth R Olivier
Journal:  Pract Radiat Oncol       Date:  2013-06-29

7.  Rapid palliative radiotherapy unit: multidisciplinary management of bone metastases.

Authors:  V Donato; M Cianciulli; M Crescenzi; A Monaco; C Caruso; A Morrone
Journal:  Radiol Med       Date:  2012-05-14       Impact factor: 3.469

8.  Pain flare after stereotactic radiosurgery for spine metastases.

Authors:  Ehsan H Balagamwala; Mihir Naik; Chandana A Reddy; Lilyana Angelov; John H Suh; Toufik Djemil; Anthony Magnelli; Samuel T Chao
Journal:  J Radiosurg SBRT       Date:  2018

9.  Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study.

Authors:  Alfonso Gomez-Iturriaga; Jon Cacicedo; Arturo Navarro; Virginia Morillo; Patricia Willisch; Claudia Carvajal; Eduardo Hortelano; Jose Luis Lopez-Guerra; Ana Illescas; Francisco Casquero; Olga Del Hoyo; Raquel Ciervide; Ana Irasarri; Jose Ignacio Pijoan; Pedro Bilbao
Journal:  BMC Palliat Care       Date:  2015-10-01       Impact factor: 3.234

10.  Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational Study.

Authors:  Amit Bahl; Herbert Hoefeler; Ignacio Duran; Guy Hechmati; Cristina Garzon-Rodriguez; John Ashcroft; Vito Lorusso; Prayashi Ghelani; Rachel Wei; Emma Thomas; Diana Lüftner
Journal:  J Clin Med       Date:  2014-07-29       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.